NCT01805141View on ClinicalTrials.gov

Phase I Pilot Study to Evaluate the Prognostic Value of Perfusion CT for Primary Cervical Cancer

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 4, 2018

Study Completion Date

October 4, 2018

Conditions
Cervical Cancer
Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT01805141 - Phase I Pilot Study to Evaluate the Prognostic Value of Perfusion CT for Primary Cervical Cancer | Biotech Hunter | Biotech Hunter